Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Omega Healthcare Investors Sees 2024 AFFO Guidance Increased To $2.78-$2.84 Per Diluted Share Vs $2.70-$2.80 Est.; Includes $648M In New Investments, Assumes Quarterly G&A Expense Of $11.5M-$13.5M, $77M In Asset Sales, And Timely Operator Restructurings And Transitions

Author: Benzinga Newsdesk | August 01, 2024 04:37pm

Posted In: OHI